Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients.
Mastorino L, Susca S, Cariti C, Sliquini N, Verrone A, Stroppiana E, Ortoncelli M, Dapavo P, Ribero S, Quaglino P. Mastorino L, et al. Among authors: cariti c. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1848-1853. doi: 10.1111/jdv.19135. Epub 2023 May 4. J Eur Acad Dermatol Venereol. 2023. PMID: 37113043
Anogenital warts treatment options: a practical approach.
Delmonte S, Benardon S, Cariti C, Ribero S, Ramoni S, Cusini M. Delmonte S, et al. Among authors: cariti c. G Ital Dermatol Venereol. 2020 Jun;155(3):261-268. doi: 10.23736/S0392-0488.18.06125-4. Epub 2018 Sep 24. G Ital Dermatol Venereol. 2020. PMID: 30251804 Free article. Review.
Infections in Sézary syndrome: A retrospective cohort study of 113 patients.
Cariti C, Quaglino P, Lupia T, Novelli M, Marra E, Fava P, Caliendo V, Tonella L, De Rosa FG, Fierro MT, Ribero S. Cariti C, et al. J Am Acad Dermatol. 2022 Apr;86(4):943-946. doi: 10.1016/j.jaad.2021.03.079. Epub 2021 May 8. J Am Acad Dermatol. 2022. PMID: 33975758 No abstract available.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
Dapavo P, Siliquini N, Mastorino L, Avallone G, Merli M, Agostini A, Cariti C, Viola R, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Ribero S. Dapavo P, et al. Among authors: cariti c. J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13. J Dermatolog Treat. 2022. PMID: 34315331 Free article.
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients.
Cariti C, Dapavo P, Mastorino L, Ortoncelli M, Siliquini N, Merli M, Avallone G, Giordano S, Fabrizio R, Susca S, Verrone A, Stroppiana E, Quaglino P, Ribero S. Cariti C, et al. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e233-e235. doi: 10.1111/jdv.17766. Epub 2021 Nov 7. J Eur Acad Dermatol Venereol. 2022. PMID: 34672026 No abstract available.
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis.
Avallone G, Cariti C, Dapavo P, Ortoncelli M, Conforto L, Mastorino L, Roccuzzo G, Cavallo F, Rubatto M, Quaglino P, Ribero S. Avallone G, et al. Among authors: cariti c. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e574-e576. doi: 10.1111/jdv.18069. Epub 2022 Mar 24. J Eur Acad Dermatol Venereol. 2022. PMID: 35279885 No abstract available.
22 results